Increased PYK2 expression was observed in early and advanced breast cancer compared to benign and normal breast tissue (39), and in pulmonary metastases, with the inhibition of PYK2 resulting in reduced tumor development and metastasis (20). Here, PTK2B is linked to breast cancer.